1992

1^st rFVIII approved by the US FDA.

Glass microbeads used as alternative to Sephadex for CAT.

Early 90s sees production of monoclonal antibodies to Rh, K, & Jk antigens for typing.

By mid 1990s all commercial anti-A & B reagents are monoclonal.

Judd describes 1^st  use of electronic crossmatch at University of Michigan Medical Centre leading to publication in Transfusion (1994).

CSL heat treat FIX concentrates to 80^oC for 72 hours similar to FVIII concentrates.